Company Filing History:
Years Active: 1990-1992
Title: Wilbur J Holtz: Innovator in HMG-CoA Reductase Inhibitors
Introduction
Wilbur J Holtz is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of HMG-CoA reductase inhibitors. With a total of 2 patents to his name, Holtz has established himself as a key figure in innovation.
Latest Patents
Holtz's latest patents include the development of 4-Substituted HMG-CoA reductase inhibitors. These inhibitors are characterized by specific formulae (I) and (II), which are disclosed in his patent documentation. This work represents a significant advancement in the treatment of conditions related to cholesterol management.
Career Highlights
Holtz is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to focus on innovative research and development in the pharmaceutical sector. His expertise in HMG-CoA reductase inhibitors has contributed to the company's portfolio of effective medications.
Collaborations
Holtz collaborates with Ta J Lee, a fellow innovator in the field. Their partnership has fostered a productive environment for research and development, leading to advancements in their shared area of expertise.
Conclusion
Wilbur J Holtz is a distinguished inventor whose work in HMG-CoA reductase inhibitors has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of effective treatments for cholesterol-related conditions.